Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Discovery Immunology is Scopus-indexed (Q2, CiteScore 4.2), DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2754-2483Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (miscellaneous) | 12 / 43 | 73rd | Q2 |
| Immunology | 150 / 243 | 38th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 4.2.
Discovery Immunology is Q2 in Immunology and Microbiology (miscellaneous) (rank 12 of 43) and Q3 in Immunology (rank 150 of 243), by CiteScore 2025.
Discovery Immunology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 4.2, quartile Q2, 73rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.079, quartile Q1, with an H-index of 9.
The publisher lists an article processing charge of about US$3,053 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Discovery Immunology is published by Oxford University Press. Its ISSN is 2754-2483.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Discovery Immunology has an h-index of 14 and a 2-year mean of 3.7 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q2. On 2-year citations it ranks #8 of 43 Scopus journals in Immunology and Microbiology (miscellaneous).
Discovery Immunology published 21 papers in 2025; its busiest recent year was 2023 with 28. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from United Kingdom (61.7%), United States (8.9%) and France (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.